0000310764-21-000111.txt : 20210728 0000310764-21-000111.hdr.sgml : 20210728 20210728141609 ACCESSION NUMBER: 0000310764-21-000111 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 66 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210728 DATE AS OF CHANGE: 20210728 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STRYKER CORP CENTRAL INDEX KEY: 0000310764 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 381239739 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-13149 FILM NUMBER: 211121826 BUSINESS ADDRESS: STREET 1: 2825 AIRVIEW BLVD CITY: KALAMAZOO STATE: MI ZIP: 49002 BUSINESS PHONE: 2693892600 MAIL ADDRESS: STREET 1: 2825 AIRVIEW BLVD CITY: KALAMAZOO STATE: MI ZIP: 49002 10-Q 1 syk-20210630.htm 10-Q syk-20210630
false2021Q2000031076412/311411310.100.1000003107642021-01-012021-06-300000310764us-gaap:CommonStockMember2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes1.125Due2021Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes0.250Due2024Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes2.125Due2027Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes0.750Due2029Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes2.625Due2030Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes1.000Due2031Member2021-01-012021-06-30xbrli:shares00003107642021-06-30iso4217:USD00003107642021-04-012021-06-3000003107642020-04-012020-06-3000003107642020-01-012020-06-30iso4217:USDxbrli:shares00003107642020-12-310000310764us-gaap:CommonStockMember2021-03-310000310764us-gaap:CommonStockMember2020-03-310000310764us-gaap:CommonStockMember2020-12-310000310764us-gaap:CommonStockMember2019-12-310000310764us-gaap:CommonStockMember2021-04-012021-06-300000310764us-gaap:CommonStockMember2020-04-012020-06-300000310764us-gaap:CommonStockMember2021-01-012021-06-300000310764us-gaap:CommonStockMember2020-01-012020-06-300000310764us-gaap:CommonStockMember2021-06-300000310764us-gaap:CommonStockMember2020-06-300000310764us-gaap:AdditionalPaidInCapitalMember2021-03-310000310764us-gaap:AdditionalPaidInCapitalMember2020-03-310000310764us-gaap:AdditionalPaidInCapitalMember2020-12-310000310764us-gaap:AdditionalPaidInCapitalMember2019-12-310000310764us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300000310764us-gaap:AdditionalPaidInCapitalMember2020-04-012020-06-300000310764us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300000310764us-gaap:AdditionalPaidInCapitalMember2020-01-012020-06-300000310764us-gaap:AdditionalPaidInCapitalMember2021-06-300000310764us-gaap:AdditionalPaidInCapitalMember2020-06-300000310764us-gaap:RetainedEarningsMember2021-03-310000310764us-gaap:RetainedEarningsMember2020-03-310000310764us-gaap:RetainedEarningsMember2020-12-310000310764us-gaap:RetainedEarningsMember2019-12-310000310764us-gaap:RetainedEarningsMember2021-04-012021-06-300000310764us-gaap:RetainedEarningsMember2020-04-012020-06-300000310764us-gaap:RetainedEarningsMember2021-01-012021-06-300000310764us-gaap:RetainedEarningsMember2020-01-012020-06-300000310764us-gaap:RetainedEarningsMember2021-06-300000310764us-gaap:RetainedEarningsMember2020-06-300000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300000310764us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300000310764us-gaap:ParentMember2021-06-300000310764us-gaap:ParentMember2020-06-300000310764us-gaap:NoncontrollingInterestMember2021-06-300000310764us-gaap:NoncontrollingInterestMember2020-06-3000003107642020-06-3000003107642019-12-310000310764syk:KneesMembersyk:OrthopaedicsMember2021-04-012021-06-300000310764syk:KneesMembersyk:OrthopaedicsMember2020-04-012020-06-300000310764syk:KneesMembersyk:OrthopaedicsMember2021-01-012021-06-300000310764syk:KneesMembersyk:OrthopaedicsMember2020-01-012020-06-300000310764syk:HipsMembersyk:OrthopaedicsMember2021-04-012021-06-300000310764syk:HipsMembersyk:OrthopaedicsMember2020-04-012020-06-300000310764syk:HipsMembersyk:OrthopaedicsMember2021-01-012021-06-300000310764syk:HipsMembersyk:OrthopaedicsMember2020-01-012020-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMember2021-04-012021-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMember2020-04-012020-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMember2021-01-012021-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMember2020-01-012020-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMember2021-04-012021-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMember2020-04-012020-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMember2021-01-012021-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMember2020-01-012020-06-300000310764syk:OrthopaedicsMember2021-04-012021-06-300000310764syk:OrthopaedicsMember2020-04-012020-06-300000310764syk:OrthopaedicsMember2021-01-012021-06-300000310764syk:OrthopaedicsMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:InstrumentsMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:InstrumentsMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:InstrumentsMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:InstrumentsMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:EndoscopyMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:EndoscopyMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:EndoscopyMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:EndoscopyMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:MedicalMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:MedicalMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:MedicalMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:MedicalMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:SustainabilityMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:SustainabilityMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:SustainabilityMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:SustainabilityMember2020-01-012020-06-300000310764syk:MedsurgMember2021-04-012021-06-300000310764syk:MedsurgMember2020-04-012020-06-300000310764syk:MedsurgMember2021-01-012021-06-300000310764syk:MedsurgMember2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMember2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMember2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMember2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMember2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMember2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMember2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMember2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMember2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMember2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMember2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMember2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMember2020-01-012020-06-300000310764syk:KneesMembersyk:OrthopaedicsMembercountry:US2021-04-012021-06-300000310764syk:KneesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:KneesMembersyk:OrthopaedicsMembercountry:US2020-04-012020-06-300000310764syk:KneesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-04-012020-06-300000310764syk:HipsMembersyk:OrthopaedicsMembercountry:US2021-04-012021-06-300000310764syk:HipsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:HipsMembersyk:OrthopaedicsMembercountry:US2020-04-012020-06-300000310764syk:HipsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-04-012020-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMembercountry:US2021-04-012021-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMembercountry:US2020-04-012020-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-04-012020-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMembercountry:US2021-04-012021-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMembercountry:US2020-04-012020-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-04-012020-06-300000310764syk:OrthopaedicsMembercountry:US2021-04-012021-06-300000310764syk:OrthopaedicsMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:OrthopaedicsMembercountry:US2020-04-012020-06-300000310764syk:OrthopaedicsMemberus-gaap:NonUsMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:InstrumentsMembercountry:US2021-04-012021-06-300000310764syk:MedsurgMembersyk:InstrumentsMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:InstrumentsMembercountry:US2020-04-012020-06-300000310764syk:MedsurgMembersyk:InstrumentsMemberus-gaap:NonUsMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:EndoscopyMembercountry:US2021-04-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:EndoscopyMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:EndoscopyMembercountry:US2020-04-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:EndoscopyMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:MedicalMembercountry:US2021-04-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:MedicalMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:MedicalMembercountry:US2020-04-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:MedicalMember2020-04-012020-06-300000310764syk:MedsurgMembersyk:SustainabilityMembercountry:US2021-04-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:SustainabilityMember2021-04-012021-06-300000310764syk:MedsurgMembersyk:SustainabilityMembercountry:US2020-04-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:SustainabilityMember2020-04-012020-06-300000310764syk:MedsurgMembercountry:US2021-04-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:MedsurgMembercountry:US2020-04-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMember2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMembercountry:US2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:NeurotechnologyMember2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMembercountry:US2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:NeurotechnologyMember2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMembercountry:US2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:SpineMember2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMembercountry:US2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:SpineMember2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMembercountry:US2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMember2021-04-012021-06-300000310764syk:NeurotechnologyAndSpineMembercountry:US2020-04-012020-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMember2020-04-012020-06-300000310764country:US2021-04-012021-06-300000310764us-gaap:NonUsMember2021-04-012021-06-300000310764country:US2020-04-012020-06-300000310764us-gaap:NonUsMember2020-04-012020-06-300000310764syk:KneesMembersyk:OrthopaedicsMembercountry:US2021-01-012021-06-300000310764syk:KneesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:KneesMembersyk:OrthopaedicsMembercountry:US2020-01-012020-06-300000310764syk:KneesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-01-012020-06-300000310764syk:HipsMembersyk:OrthopaedicsMembercountry:US2021-01-012021-06-300000310764syk:HipsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:HipsMembersyk:OrthopaedicsMembercountry:US2020-01-012020-06-300000310764syk:HipsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-01-012020-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMembercountry:US2021-01-012021-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMembercountry:US2020-01-012020-06-300000310764syk:TraumaandExtremitiesMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-01-012020-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMembercountry:US2021-01-012021-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMembercountry:US2020-01-012020-06-300000310764syk:OtherOrthopaedicsMembersyk:OrthopaedicsMemberus-gaap:NonUsMember2020-01-012020-06-300000310764syk:OrthopaedicsMembercountry:US2021-01-012021-06-300000310764syk:OrthopaedicsMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:OrthopaedicsMembercountry:US2020-01-012020-06-300000310764syk:OrthopaedicsMemberus-gaap:NonUsMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:InstrumentsMembercountry:US2021-01-012021-06-300000310764syk:MedsurgMembersyk:InstrumentsMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:InstrumentsMembercountry:US2020-01-012020-06-300000310764syk:MedsurgMembersyk:InstrumentsMemberus-gaap:NonUsMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:EndoscopyMembercountry:US2021-01-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:EndoscopyMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:EndoscopyMembercountry:US2020-01-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:EndoscopyMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:MedicalMembercountry:US2021-01-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:MedicalMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:MedicalMembercountry:US2020-01-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:MedicalMember2020-01-012020-06-300000310764syk:MedsurgMembersyk:SustainabilityMembercountry:US2021-01-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:SustainabilityMember2021-01-012021-06-300000310764syk:MedsurgMembersyk:SustainabilityMembercountry:US2020-01-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMembersyk:SustainabilityMember2020-01-012020-06-300000310764syk:MedsurgMembercountry:US2021-01-012021-06-300000310764syk:MedsurgMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:MedsurgMembercountry:US2020-01-012020-06-300000310764syk:MedsurgMemberus-gaap:NonUsMember2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMembercountry:US2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:NeurotechnologyMember2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:NeurotechnologyMembercountry:US2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:NeurotechnologyMember2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMembercountry:US2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:SpineMember2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMembersyk:SpineMembercountry:US2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMembersyk:SpineMember2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMembercountry:US2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMember2021-01-012021-06-300000310764syk:NeurotechnologyAndSpineMembercountry:US2020-01-012020-06-300000310764syk:NeurotechnologyAndSpineMemberus-gaap:NonUsMember2020-01-012020-06-300000310764country:US2021-01-012021-06-300000310764us-gaap:NonUsMember2021-01-012021-06-300000310764country:US2020-01-012020-06-300000310764us-gaap:NonUsMember2020-01-012020-06-300000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-03-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-03-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2021-03-3100003107642021-03-310000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-04-012021-06-300000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-012021-06-300000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-04-012021-06-300000310764us-gaap:AccumulatedTranslationAdjustmentMember2021-04-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-04-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-04-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2021-04-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-06-300000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-06-300000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-06-300000310764us-gaap:AccumulatedTranslationAdjustmentMember2021-06-300000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-03-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-03-310000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-03-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2020-03-3100003107642020-03-310000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-04-012020-06-300000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-04-012020-06-300000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-04-012020-06-300000310764us-gaap:AccumulatedTranslationAdjustmentMember2020-04-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-04-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-04-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-04-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2020-04-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-04-012020-06-300000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-06-300000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-300000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-06-300000310764us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-12-310000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-06-300000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-06-300000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-06-300000310764us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-06-300000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2019-12-310000310764us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000310764us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-06-300000310764us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-06-300000310764us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-06-300000310764us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-01-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-06-300000310764us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-01-012020-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:ForeignExchangeContractMember2021-01-012021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:ForeignExchangeContractMember2020-01-012020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:OtherCurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:OtherNoncurrentAssetsMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:OtherCurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:OtherCurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2020-12-310000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:ForeignExchangeContractMember2020-12-31iso4217:EUR0000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2021-04-012021-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2020-04-012020-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2021-01-012021-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:CostOfSalesMember2020-01-012020-06-300000310764us-gaap:NetInvestmentHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-04-012021-06-300000310764us-gaap:NetInvestmentHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-04-012020-06-300000310764us-gaap:NetInvestmentHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-06-300000310764us-gaap:NetInvestmentHedgingMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-04-012021-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-04-012020-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2021-01-012021-06-300000310764us-gaap:ForeignExchangeContractMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-06-300000310764us-gaap:ForeignExchangeContractMember2021-04-012021-06-300000310764us-gaap:ForeignExchangeContractMember2020-04-012020-06-300000310764us-gaap:ForeignExchangeContractMember2020-01-012020-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:ForeignExchangeContractMember2021-01-012021-06-300000310764us-gaap:InterestRateSwapMember2021-01-012021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2021-06-300000310764us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-01-012021-06-300000310764us-gaap:FairValueInputsLevel1Member2021-06-300000310764us-gaap:FairValueInputsLevel1Member2020-12-310000310764us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2021-06-300000310764us-gaap:FairValueInputsLevel2Memberus-gaap:AssetBackedSecuritiesMember2020-12-310000310764us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2021-06-300000310764us-gaap:FairValueInputsLevel2Memberus-gaap:USGovernmentAgenciesDebtSecuritiesMember2020-12-310000310764us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2021-06-300000310764us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasurySecuritiesMember2020-12-310000310764us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-06-300000310764us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310000310764us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMember2021-06-300000310764us-gaap:FairValueInputsLevel2Memberus-gaap:CertificatesOfDepositMember2020-12-310000310764us-gaap:FairValueInputsLevel2Member2021-06-300000310764us-gaap:FairValueInputsLevel2Member2020-12-310000310764us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2021-06-300000310764us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2020-12-310000310764us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2021-06-300000310764us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2020-12-310000310764us-gaap:FairValueInputsLevel3Member2020-12-310000310764us-gaap:FairValueInputsLevel3Member2019-12-310000310764us-gaap:FairValueInputsLevel3Member2021-01-012021-06-300000310764us-gaap:FairValueInputsLevel3Member2020-01-012020-12-310000310764us-gaap:FairValueInputsLevel3Member2021-06-300000310764srt:MinimumMember2021-06-300000310764srt:MaximumMember2021-06-30xbrli:pure0000310764syk:WrightMember2020-11-012020-11-3000003107642020-11-012020-11-300000310764syk:WrightMember2020-12-310000310764syk:WrightMembersyk:CustomerAndDistributorRelationshipsMember2020-12-310000310764us-gaap:DevelopedTechnologyRightsMembersyk:WrightMember2020-12-310000310764syk:WrightMemberus-gaap:TradeNamesMember2020-12-310000310764syk:WrightMember2020-01-012020-12-310000310764us-gaap:CommercialPaperMembersrt:MaximumMember2021-06-300000310764us-gaap:CommercialPaperMember2021-01-012021-06-30utr:Rate0000310764syk:SeniorUnsecuredNotes2625Due2021Member2021-06-300000310764syk:SeniorUnsecuredNotes2625Due2021Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes2625Due2021Member2020-12-310000310764syk:SeniorUnsecuredNotes1.125Due2021Member2021-06-300000310764syk:SeniorUnsecuredNotes1.125Due2021Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes1.125Due2021Member2020-12-310000310764syk:SeniorUnsecuredNotes0600Due2023Member2021-06-300000310764syk:SeniorUnsecuredNotes0600Due2023Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes0600Due2023Member2020-12-310000310764syk:SeniorUnsecuredNotes3.375due2024Member2021-06-300000310764syk:SeniorUnsecuredNotes3.375due2024Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes3.375due2024Member2020-12-310000310764syk:SeniorUnsecuredNotes0.250Due2024Member2021-06-300000310764syk:SeniorUnsecuredNotes0.250Due2024Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes0.250Due2024Member2020-12-310000310764syk:SeniorUnsecuredNotes1.150Due2025Member2021-06-300000310764syk:SeniorUnsecuredNotes1.150Due2025Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes1.150Due2025Member2020-12-310000310764syk:SeniorUnsecuredNotes3.375due2025MemberMember2021-06-300000310764syk:SeniorUnsecuredNotes3.375due2025MemberMember2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes3.375due2025MemberMember2020-12-310000310764syk:SeniorUnsecuredNotes350Due2026Member2021-06-300000310764syk:SeniorUnsecuredNotes350Due2026Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes350Due2026Member2020-12-310000310764syk:SeniorUnsecuredNotes2.125Due2027Member2021-06-300000310764syk:SeniorUnsecuredNotes2.125Due2027Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes2.125Due2027Member2020-12-310000310764syk:SeniorUnsecuredNotes3650Due2028Member2021-06-300000310764syk:SeniorUnsecuredNotes3650Due2028Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes3650Due2028Member2020-12-310000310764syk:SeniorUnsecuredNotes0.750Due2029Member2021-06-300000310764syk:SeniorUnsecuredNotes0.750Due2029Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes0.750Due2029Member2020-12-310000310764syk:SeniorUnsecuredNotes1.950Due2030Member2021-06-300000310764syk:SeniorUnsecuredNotes1.950Due2030Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes1.950Due2030Member2020-12-310000310764syk:SeniorUnsecuredNotes2.625Due2030Member2021-06-300000310764syk:SeniorUnsecuredNotes2.625Due2030Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes2.625Due2030Member2020-12-310000310764syk:SeniorUnsecuredNotes1.000Due2031Member2021-06-300000310764syk:SeniorUnsecuredNotes1.000Due2031Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes1.000Due2031Member2020-12-310000310764syk:SeniorUnsecuredNotes410Due2043Member2021-06-300000310764syk:SeniorUnsecuredNotes410Due2043Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes410Due2043Member2020-12-310000310764syk:SeniorUnsecuredNotes4.375due2044Member2021-06-300000310764syk:SeniorUnsecuredNotes4.375due2044Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes4.375due2044Member2020-12-310000310764syk:SeniorUnsecuredNotes4625Due2046Member2021-06-300000310764syk:SeniorUnsecuredNotes4625Due2046Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes4625Due2046Member2020-12-310000310764syk:SeniorUnsecuredNotes2.900due2050Member2021-06-300000310764syk:SeniorUnsecuredNotes2.900due2050Member2021-01-012021-06-300000310764syk:SeniorUnsecuredNotes2.900due2050Member2020-12-310000310764syk:TermLoanMember2021-01-012021-06-300000310764syk:TermLoanMember2021-06-300000310764syk:TermLoanMember2020-12-310000310764syk:SeniorUnsecuredNotes2625Due2021Member2021-03-310000310764us-gaap:OperatingSegmentsMembersyk:OrthopaedicsMember2021-04-012021-06-300000310764us-gaap:OperatingSegmentsMembersyk:OrthopaedicsMember2020-04-012020-06-300000310764us-gaap:OperatingSegmentsMembersyk:OrthopaedicsMember2021-01-012021-06-300000310764us-gaap:OperatingSegmentsMembersyk:OrthopaedicsMember2020-01-012020-06-300000310764us-gaap:OperatingSegmentsMembersyk:MedsurgMember2021-04-012021-06-300000310764us-gaap:OperatingSegmentsMembersyk:MedsurgMember2020-04-012020-06-300000310764us-gaap:OperatingSegmentsMembersyk:MedsurgMember2021-01-012021-06-300000310764us-gaap:OperatingSegmentsMembersyk:MedsurgMember2020-01-012020-06-300000310764us-gaap:OperatingSegmentsMembersyk:NeurotechnologyAndSpineMember2021-04-012021-06-300000310764us-gaap:OperatingSegmentsMembersyk:NeurotechnologyAndSpineMember2020-04-012020-06-300000310764us-gaap:OperatingSegmentsMembersyk:NeurotechnologyAndSpineMember2021-01-012021-06-300000310764us-gaap:OperatingSegmentsMembersyk:NeurotechnologyAndSpineMember2020-01-012020-06-300000310764us-gaap:OperatingSegmentsMember2021-04-012021-06-300000310764us-gaap:OperatingSegmentsMember2020-04-012020-06-300000310764us-gaap:OperatingSegmentsMember2021-01-012021-06-300000310764us-gaap:OperatingSegmentsMember2020-01-012020-06-300000310764us-gaap:CorporateNonSegmentMember2021-04-012021-06-300000310764us-gaap:CorporateNonSegmentMember2020-04-012020-06-300000310764us-gaap:CorporateNonSegmentMember2021-01-012021-06-300000310764us-gaap:CorporateNonSegmentMember2020-01-012020-06-300000310764us-gaap:MaterialReconcilingItemsMember2021-04-012021-06-300000310764us-gaap:MaterialReconcilingItemsMember2020-04-012020-06-300000310764us-gaap:MaterialReconcilingItemsMember2021-01-012021-06-300000310764us-gaap:MaterialReconcilingItemsMember2020-01-012020-06-300000310764srt:ScenarioForecastMember2021-01-012021-12-3100003107642020-01-012020-12-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2021
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-13149
syk-20210630_g1.jpg
STRYKER CORPORATION
(Exact name of registrant as specified in its charter)
Michigan38-1239739
(State of incorporation)(I.R.S. Employer Identification No.)
2825 Airview Boulevard Kalamazoo,Michigan49002
(Address of principal executive offices)(Zip Code)
(269)385-2600
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $.10 Par ValueSYKNew York Stock Exchange
1.125% Notes due 2023SYK23New York Stock Exchange
0.250% Notes due 2024SYK24ANew York Stock Exchange
2.125% Notes due 2027SYK27New York Stock Exchange
0.750% Notes due 2029SYK29New York Stock Exchange
2.625% Notes due 2030SYK30New York Stock Exchange
1.000% Notes due 2031SYK31New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes     No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes     No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Emerging growth company
Non-accelerated filer
Small reporting company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes     No
There were 377,096,272 shares of Common Stock, $0.10 par value, on June 30, 2021.

STRYKER CORPORATION2021 Second Quarter Form 10-Q
PART I – FINANCIAL INFORMATION
ITEM 1.FINANCIAL STATEMENTS
Stryker Corporation and Subsidiaries
CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) (Unaudited)
Three MonthsSix Months
2021202020212020
Net sales$4,294 $2,764 $8,247 $6,352 
Cost of sales1,522 1,216 2,966 2,473 
Gross profit$2,772 $1,548 $5,281 $3,879 
Research, development and engineering expenses310 233 598 487 
Selling, general and administrative expenses1,505 1,225 3,080 2,555 
Recall charges76  82 (6)
Amortization of intangible assets149 110 330 228 
Total operating expenses$2,040 $1,568 $4,090 $3,264 
Operating income (loss)$732 $(20)$1,191 $615 
Other income (expense), net(70)(67)(162)(112)
Earnings (loss) before income taxes$662 $(87)$1,029 $503 
Income taxes70 (4)135 93 
Net earnings (loss)$592 $(83)$894 $410 
Net earnings (loss) per share of common stock:
Basic$1.57 $(0.22)$2.37 $1.09 
Diluted$1.55 $(0.22)$2.34 $1.08 
Weighted-average shares outstanding (in millions):
Basic376.9 375.5 376.6 375.1 
Effect of dilutive employee stock compensation5.4  5.4 4.8 
Diluted382.3 375.5 382.0 379.9 
Cash dividends declared per share of common stock$0.63 $0.575 $1.26 $1.15 
Anti-dilutive shares excluded from the calculation of dilutive employee stock options were 4.3 for the three months 2020 and de minimis in all other periods.


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)
Three MonthsSix Months
2021202020212020
Net earnings (loss)$592 $(83)$894 $410 
Other comprehensive income (loss), net of tax:
Pension plans(4)(4)3 (8)
Unrealized gains (losses) on designated hedges8 (30)36 (56)
Financial statement translation(80)(58)175 (45)
Total other comprehensive income (loss), net of tax$(76)$(92)$214 $(109)
Comprehensive income (loss)$516 $(175)$1,108 $301 

See accompanying notes to Consolidated Financial Statements.
Dollar amounts are in millions except per share amounts or as otherwise specified.
1

STRYKER CORPORATION2021 Second Quarter Form 10-Q
CONSOLIDATED BALANCE SHEETS
June 30December 31
20212020
(Unaudited)
Assets
Current assets
Cash and cash equivalents$2,241 $2,943 
Marketable securities84 81 
Accounts receivable, less allowance of $141 ($131 in 2020)2,714 2,701 
Inventories:
Materials and supplies658 678 
Work in process264 251 
Finished goods2,509 2,565 
Total inventories$3,431 $3,494 
Prepaid expenses and other current assets562 488 
Total current assets$9,032 $9,707 
Property, plant and equipment:
Land, buildings and improvements1,607 1,546 
Machinery and equipment3,755 3,636 
Total property, plant and equipment$5,362 $5,182 
Less accumulated depreciation2,624 2,430 
Property, plant and equipment, net$2,738 $2,752 
Goodwill12,802 12,778 
Other intangibles, net5,261 5,554 
Noncurrent deferred income tax assets1,751 1,530 
Other noncurrent assets2,114 2,009 
Total assets$33,698 $34,330 
Liabilities and shareholders' equity
Current liabilities
Accounts payable$864 $810 
Accrued compensation890 925 
Income taxes300 207 
Dividends payable238 237 
Accrued product liabilities444 515 
Accrued expenses and other liabilities1,510 1,586 
Current maturities of debt6 761 
Total current liabilities$4,252 $5,041 
Long-term debt, excluding current maturities12,734 13,230 
Income taxes927 990 
Other noncurrent liabilities1,965 1,985 
Total liabilities$19,878 $21,246 
Shareholders' equity
Common stock, $0.10 par value38 38 
Additional paid-in capital1,844 1,741 
Retained earnings12,881 12,462 
Accumulated other comprehensive loss(943)(1,157)
Total shareholders' equity$13,820 $13,084 
Total liabilities and shareholders' equity$33,698 $34,330 

See accompanying notes to Consolidated Financial Statements.
Dollar amounts are in millions except per share amounts or as otherwise specified.
2

STRYKER CORPORATION2021 Second Quarter Form 10-Q
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)
Three MonthsSix Months
2021202020212020
Common stock shares outstanding (in millions)
Beginning376.7 375.4 376.1 374.5 
Issuance of common stock under stock compensation and benefit plans0.4 0.2 1.0 1.1 
Repurchase of common stock    
Ending377.1 375.6 377.1 375.6 
Common stock
Beginning$38 $38 $38 $37 
Issuance of common stock under stock compensation and benefit plans   1 
Repurchase of common stock    
Ending$38 $38 $38 $38 
Additional paid-in capital
Beginning$1,806 $1,676 $1,741 $1,628 
Issuance of common stock under stock compensation and benefit plans(1) (4)(8)
Repurchase of common stock    
Share-based compensation39 30 107 86 
Ending$1,844 $1,706 $1,844 $1,706 
Retained earnings
Beginning$12,525 $12,024 $12,462 $11,748 
Net earnings (loss)592 (83)894 410 
Repurchase of common stock    
Cash dividends declared(236)(216)(475)(433)
Ending$12,881 $11,725 $12,881 $11,725 
Accumulated other comprehensive income (loss)
Beginning$(867)$(623)$(1,157)$(606)
Other comprehensive income (loss)(76)(92)214 (109)
Ending$(943)$(715)$(943)$(715)
Total Stryker shareholders' equity$13,820 $12,754 $13,820 $12,754 
Non-controlling interest    
Total shareholders' equity$13,820 $12,754 $13,820 $12,754 

See accompanying notes to Consolidated Financial Statements.
Dollar amounts are in millions except per share amounts or as otherwise specified.
3

STRYKER CORPORATION2021 Second Quarter Form 10-Q
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
Six Months
20212020
Operating activities
Net earnings$894 $410 
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation187 163 
Amortization of intangible assets330 228 
Asset impairments3 161 
Share-based compensation107 86 
Recall charges82 (6)
Sale of inventory stepped-up to fair value at acquisition137 9 
Changes in operating assets and liabilities:
Accounts receivable(24)671 
Inventories(128)(181)
Accounts payable57 (34)
Accrued expenses and other liabilities22 (375)
Recall-related payments(163)(12)
Income taxes(98)(39)
Other, net(76)130 
Net cash provided by operating activities$1,330 $1,211 
Investing activities
Acquisitions, net of cash acquired(104)(26)
Purchases of marketable securities(31)(23)
Proceeds from sales of marketable securities28 31 
Purchases of property, plant and equipment(189)(253)
Other investing, net(2)(9)
Net cash used in investing activities$(298)$(280)
Financing activities
Proceeds (payments) on short-term borrowings, net(7)8 
Proceeds from issuance of long-term debt5 2,293 
Payments on long-term debt(1,151)(500)
Dividends paid(475)(431)
Repurchases of common stock  
Cash paid for taxes from withheld shares(74)(68)
Other financing, net(27)(14)
Net cash provided by (used in) financing activities$(1,729)$1,288 
Effect of exchange rate changes on cash and cash equivalents(5)(17)
Change in cash and cash equivalents$(702)$2,202 
Cash and cash equivalents at beginning of period2,943 4,337 
Cash and cash equivalents at end of period$2,241 $6,539 

See accompanying notes to Consolidated Financial Statements.
Dollar amounts are in millions except per share amounts or as otherwise specified.
4

STRYKER CORPORATION2021 Second Quarter Form 10-Q
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
NOTE 1 - BASIS OF PRESENTATION
General Information
Management believes the accompanying unaudited Consolidated Financial Statements contain all adjustments, including normal recurring items, considered necessary to fairly present the financial position of Stryker Corporation and its consolidated subsidiaries ("Stryker," the "Company," "we," us" or "our") on June 30, 2021 and the results of operations for the three and six months 2021. The results of operations included in these Consolidated Financial Statements may not necessarily be indicative of our annual results. These statements should be read in conjunction with our Annual Report on Form 10-K for 2020.
New Accounting Pronouncements Not Yet Adopted
We evaluate all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB) for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our Consolidated Financial Statements.
NOTE 2 - REVENUE RECOGNITION
Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for 2020.
We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.
Net Sales by Product Line
Three MonthsSix Months
2021202020212020
Orthopaedics:
Knees$474 $241 $886 $673 
Hips353 216 662 532 
Trauma and Extremities674 330 1,314 722 
Other127 107 250 189 
$1,628 $894 $3,112 $2,116 
MedSurg:
Instruments$517 $328 $986 $841 
Endoscopy518 316 987 771 
Medical640 632 1,262 1,219 
Sustainability73 48 134 115 
$1,748 $1,324 $3,369 $2,946 
Neurotechnology and Spine:
Neurotechnology$611 $369 $1,181 $852 
Spine307 177 585 438 
$918 $546 $1,766 $1,290 
Total$4,294 $2,764 $8,247 $6,352 
Net Sales by Geography
Three Months 2021Three Months 2020
United StatesInternationalUnited StatesInternational
Orthopaedics:
Knees$349 $125 $179 $62 
Hips221 132 140 76 
Trauma and Extremities475 199 208 122 
Other99 28 96 11 
$1,144 $484 $623 $271 
MedSurg:
Instruments$401 $116 $249 $79 
Endoscopy407 111 253 63 
Medical488 152 454 178 
Sustainability72 1 48  
$1,368 $380 $1,004 $320 
Neurotechnology and Spine:
Neurotechnology$371 $240 $211 $158 
Spine217 90 128 49 
$588 $330 $339 $207 
Total$3,100 $1,194 $1,966 $798 
Net Sales by Geography
Six Months 2021Six Months 2020
United StatesInternationalUnited StatesInternational
Orthopaedics:
Knees$643 $243 $501 $172 
Hips407 255 341 191 
Trauma and Extremities915 399 468 254 
Other193 57 165 24 
$2,158 $954 $1,475 $641 
MedSurg:
Instruments$756 $230 $659 $182 
Endoscopy761 226 617 154 
Medical961 301 908 311 
Sustainability132 2 114 1 
$2,610 $759 $2,298 $648 
Neurotechnology and Spine:
Neurotechnology$706 $475 $512 $340 
Spine410 175 324 114 
$1,116 $650 $836 $454 
Total$5,884 $2,363 $4,609 $1,743 
Contract Assets and Liabilities
On June 30, 2021 and December 31, 2020 contract assets recorded in our Consolidated Balance Sheets were not significant.
Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $476 and $416 on June 30, 2021 and December 31, 2020.
Dollar amounts are in millions except per share amounts or as otherwise specified.
5

STRYKER CORPORATION2021 Second Quarter Form 10-Q
NOTE 3 - ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)
Three Months 2021Marketable SecuritiesPension PlansHedgesFinancial Statement TranslationTotal
Beginning$(3)$(252)$18 $(630)$(867)
OCI  (9)7 (75)(77)
Income taxes 2 (3)2 1 
Reclassifications to:
Cost of sales  4  4 
Other (income) expense 4 (1)(9)(6)
Income taxes (1)1 2 2 
Net OCI$ $(4)$8 $(80)$(76)
Ending$(3)$(256)$26 $(710)$(943)
Three Months 2020Marketable SecuritiesPension PlansHedgesFinancial Statement TranslationTotal
Beginning$(3)$(183)$21 $(458)$(623)
OCI (1)(8)(33)(91)(133)
Income taxes 2 8 39 49 
Reclassifications to:
Cost of sales  (3) (3)
Other (income) expense1 3 (2)(7)(5)
Income taxes (1) 1  
Net OCI$ $(4)$(30)$(58)$(92)
Ending$(3)$(187)$(9)$(516)$(715)
Six Months 2021Marketable SecuritiesPension PlansHedgesFinancial Statement TranslationTotal
Beginning$(3)$(259)$(10)$(885)$(1,157)
OCI  (1)34 198 231 
Income taxes (2)(11)(10)(23)
Reclassifications to:
Cost of sales  5  5 
Other (income) expe